{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:25:09Z","timestamp":1793694309510,"version":"4.5.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Justice"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Continuation or initiation of MOUDs during incarceration could improve post-release outcomes by preventing return to opioid use and reducing risk of overdose. People with OUD involved in the criminal legal system are a vulnerable population, yet little research has comprehensively examined post-release outcomes associated with receiving MOUDs in jail and prison settings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The authors conducted a review of published peer-reviewed literature on post-release outcomes associated with the use of MOUDs in correctional settings to determine implications for further research and policy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Results showed compelling evidence supporting the use of MOUDs for currently incarcerated populations, with almost all studies showing that MOUDs provided during incarceration increased community-based treatment engagement post-release. There is also evidence that initiating or continuing MOUDs during incarceration is associated with decreased opioid use and overdoses post-release, without increasing criminal involvement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Findings indicate that forcing tapering and withdrawal during incarceration can have dire consequences upon release into the community. Initiating or continuing MOUDs during incarceration reduces the risk for opioid use and overdose upon release by maintaining opioid tolerance and increasing community treatment engagement.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40352-023-00209-w","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T04:55:41Z","timestamp":1675486541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Medications for opioid use disorder during incarceration and post-release outcomes"],"prefix":"10.1186","volume":"11","author":[{"given":"Lara","family":"Cates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-0338","authenticated-orcid":false,"given":"Aaron R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"key":"209_CR1","doi-asserted-by":"publisher","DOI":"10.17226\/25310","volume-title":"Medications for opioid use disorder save lives","author":"N Academies","year":"2019","unstructured":"Academies, N., & of Sciences, Engineering, and Medicine (2019). Medications for opioid use disorder save lives. Washington, DC: The National Academies Press. https:\/\/doi.org\/10.17226\/25310."},{"key":"209_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","volume":"159","author":"IA Binswanger","year":"2013","unstructured":"Binswanger, I. A., Blatchford, P. J., Mueller, S. R., & Stern, M. F. (2013). Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Annals of Internal Medicine, 159, 592\u2013600. https:\/\/doi.org\/10.7326\/0003-4819-159-9-201311050-00005.","journal-title":"Annals of Internal Medicine"},{"key":"209_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2017.11.023","volume":"184","author":"L Brinkley-Rubinstein","year":"2018","unstructured":"Brinkley-Rubinstein, L., McKenzie, M., Macmadu, A., Larney, S., Zaller, N., Dauria, E., & Rich, J. (2018). A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug and Alcohol Dependence, 184, 57\u201363. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.11.023.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR4","volume-title":"Methadone treatment for people who use fentanyl: Recommendations","author":"L Bromley","year":"2021","unstructured":"Bromley, L., Meldon, K., Regenstreif, L., Srivastava, A., & Wyman, J. (2021). Methadone treatment for people who use fentanyl: Recommendations. Toronto: META:PHI http:\/\/www.metaphi.ca\/wp-content\/uploads\/Guide_MethadoneForFentanyl.pdf."},{"key":"209_CR5","volume-title":"Drug overdose deaths in the U.S. top 100,000 annually","author":"Centers for Disease Control and Prevention","year":"2021","unstructured":"Centers for Disease Control and Prevention (2021). U.S. Department of Health and Human Services. In  Drug overdose deaths in the U.S. top 100,000 annually https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm."},{"key":"209_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","volume":"63","author":"SD Comer","year":"2006","unstructured":"Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., \u2026 O\u2019Brien, C. P. (2006). Injectable, sustained-release naltrexone for the treatment of opioid dependence: A randomized, placebo-controlled trial. Archives of General Psychiatry, 63, 210\u2013218. https:\/\/doi.org\/10.1001\/archpsyc.63.2.210.","journal-title":"Archives of General Psychiatry"},{"key":"209_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/epirev\/mxy004","volume":"40","author":"D de Andrade","year":"2018","unstructured":"de Andrade, D., Ritchie, J., Rowlands, M., Mann, E., & Hides, L. (2018). Substance use and recidivism outcomes for prison-based drug and alcohol interventions. Epidemiologic Reviews, 40, 121\u2013133. https:\/\/doi.org\/10.1093\/epirev\/mxy004.","journal-title":"Epidemiologic Reviews"},{"key":"209_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/add.12536","volume":"109","author":"L Degenhardt","year":"2014","unstructured":"Degenhardt, L., Larney, S., Kimber, J., Gisev, N., Farrell, M., Dobbins, T., \u2026 Burns, L. (2014). The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study. Addiction (Abingdon, England), 109, 1306\u20131317. https:\/\/doi.org\/10.1111\/add.12536.","journal-title":"Addiction (Abingdon, England)"},{"key":"209_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/phe\/phw040","volume":"12","author":"D D'Hotman","year":"2019","unstructured":"D'Hotman, D., Pugh, J., & Douglas, T. (2019). The case against forced methadone detox in the US prisons. Public Health Ethics, 12, 89\u201393. https:\/\/doi.org\/10.1093\/phe\/phw040.","journal-title":"Public Health Ethics"},{"issue":"25","key":"209_CR10","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJM196906192802502","volume":"280","author":"VP Dole","year":"1969","unstructured":"Dole, V. P., Robinson, J. W., Orraca, J., Towns, E., Searcy, P., & Caine, E. (1969). Methadone treatment of randomly selected criminal addicts. New England Journal of Medicine, 280(25), 1372\u20131375. https:\/\/doi.org\/10.1056\/NEJM196906192802502.","journal-title":"New England Journal of Medicine"},{"key":"209_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2021.109254","volume":"231","author":"EA Evans","year":"2022","unstructured":"Evans, E. A., Wilson, D., & Friedmann, P. D. (2022). Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence, 231, 1\u20135. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109254.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jsat.2020.108076","volume":"117","author":"D Farabee","year":"2020","unstructured":"Farabee, D., Condon, T., Hallgren, K. A., & McCrady, B. (2020). A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder. Journal of Substance Abuse Treatment, 117, 8. https:\/\/doi.org\/10.1016\/j.jsat.2020.108076.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"209_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/jurban\/jth147","volume":"81","author":"K Fiscella","year":"2004","unstructured":"Fiscella, K., Moore, A., Engerman, J., & Meldrum, S. (2004). Jail management of arrestees\/inmates enrolled in community methadone maintenance programs. Journal of Urban Health, 81, 645\u2013654. https:\/\/doi.org\/10.1093\/jurban\/jth147.","journal-title":"Journal of Urban Health"},{"key":"209_CR14","unstructured":"Food and Drug Administration. (2019). Information about medication-assisted treatment. https:\/\/www.fda.gov\/drugs\/information-drug-class\/information-about-medication-assisted-treatment-mat"},{"key":"209_CR15","doi-asserted-by":"publisher","unstructured":"Friedmann, P. D., Wilson, D., Hoskinson Jr, R., Poshkus, M., & Clarke, J. G. (2018). Initiation of extended-release naltrexone (XR-NTX) for opioid use disorder prior to release from prison. Journal of Substance Abuse Treatment, 85, 45\u201348. https:\/\/doi.org\/10.1016\/j.jsat.2017.04.010","DOI":"10.1016\/j.jsat.2017.04.010"},{"key":"209_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1056\/NEJMoa022164","volume":"349","author":"PJ Fudala","year":"2003","unstructured":"Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., \u2026 Buprenorphine\/Naloxone Collaborative Study Group (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. The New England Journal of Medicine, 349, 949\u2013958. https:\/\/doi.org\/10.1056\/NEJMoa022164.","journal-title":"The New England Journal of Medicine"},{"key":"209_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.drugalcdep.2018.04.010","volume":"188","author":"M Gordon","year":"2018","unstructured":"Gordon, M., Blue, T., Couvillion, K., Schwartz, R., O\u2019Grady, K., Fitzgerald, T., & Vocci, F. (2018). Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes. Drug and Alcohol Dependence, 188, 232\u2013238. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.010.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","volume":"142","author":"MS Gordon","year":"2014","unstructured":"Gordon, M. S., Kinlock, T. W., Schwartz, R. P., Fitzgerald, T. T., O\u2019Grady, K. E., & Vocci, F. J. (2014). A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry. Drug and Alcohol Dependence, 142, 33\u201340. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.05.011.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","volume":"103","author":"MS Gordon","year":"2008","unstructured":"Gordon, M. S., Kinlock, T. W., Schwartz, R. P., & O\u2019Grady, K. E. (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6 months post-release. Addiction (Abingdon, England), 103, 1333\u20131342. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.002238.x.","journal-title":"Addiction (Abingdon, England)"},{"key":"209_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.11.037","volume":"172","author":"MS Gordon","year":"2017","unstructured":"Gordon, M. S., Kinlock, T. W., Schwartz, R. P., O\u2019Grady, K. E., Fitzgerald, T. T., & Vocci, F. J. (2017). A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release. Drug and Alcohol Dependence, 172, 34\u201342. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.037.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","volume":"59","author":"MS Gordon","year":"2015","unstructured":"Gordon, M. S., Kinlock, T. W., Vocci, F. J., Fitzgerald, T. T., Memisoglu, A., & Silverman, B. (2015). A phase 4, pilot, open-label study of VIVITROL\u00ae(extended-release naltrexone XR-NTX) for prisoners. Journal of Substance Abuse Treatment, 59, 52\u201358. https:\/\/doi.org\/10.1016\/j.jsat.2015.07.005.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"209_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","volume":"75","author":"TC Green","year":"2018","unstructured":"Green, T. C., Clarke, J., Brinkley-Rubinstein, L., Marshall, B. D., Alexander-Scott, N., Boss, R., & Rich, J. D. (2018). Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiatry, 75(4), 405\u2013407. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4614.","journal-title":"JAMA Psychiatry"},{"key":"209_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2021.108937","volume":"227","author":"A Haas","year":"2021","unstructured":"Haas, A., Viera, A., Doernberg, M., Barbour, R., Tong, G., Grau, L. E., & Heimer, R. (2021). Post-incarceration outcomes for individuals who continued methadone treatment while in Connecticut jails, 2014\u20132018. Drug and Alcohol Dependence, 227, 1\u20136. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108937.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-244X-12-111","volume":"12","author":"A H\u00e5kansson","year":"2012","unstructured":"H\u00e5kansson, A., & Berglund, M. (2012). Risk factors for criminal recidivism - a prospective follow-up study in prisoners with substance abuse. BMC Psychiatry, 12, 111\u2013111. https:\/\/doi.org\/10.1186\/1471-244X-12-111.","journal-title":"BMC Psychiatry"},{"key":"209_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","volume":"14","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey, P. J., Khan, M. R., Wang, E. A., Scheidell, J. D., Edelman, E. J., McInnes, D. K., & Fox, A. D. (2019). A conceptual model for understanding post-release opioid-related overdose risk. Addiction Science & Clinical Practice, 14, 17\u201314. https:\/\/doi.org\/10.1186\/s13722-019-0145-5.","journal-title":"Addiction Science & Clinical Practice"},{"key":"209_CR26","doi-asserted-by":"publisher","first-page":"108006","DOI":"10.1016\/j.jsat.2020.108006","volume":"113","author":"SM Kelly","year":"2020","unstructured":"Kelly, S. M., Schwartz, R. P., O'Grady, K. E., Mitchell, S. G., Duren, T., Sharma, A., & Jaffe, J. H. (2020). Impact of methadone treatment initiated in jail on subsequent arrest. Journal of Substance Abuse Treatment, 113, 108006\u2013108007. https:\/\/doi.org\/10.1016\/j.jsat.2020.108006.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"209_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1081\/ADA-200056804","volume":"31","author":"T Kinlock","year":"2005","unstructured":"Kinlock, T., Battjes, R., Schwartz, R., & MTC Project Team (2005). A novel opioid maintenance program for prisoners: Report of post-release outcomes. American Journal of Drug and Alcohol Abuse, 31, 433\u2013454. https:\/\/doi.org\/10.1081\/ADA-200056804.","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"209_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","volume":"37","author":"TW Kinlock","year":"2009","unstructured":"Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O\u2019Grady, K. E. (2009). A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months post release. Journal of Substance Abuse Treatment, 37, 277\u2013285. https:\/\/doi.org\/10.1016\/j.jsat.2009.03.002.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"209_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","volume":"91","author":"TW Kinlock","year":"2007","unstructured":"Kinlock, T. W., Gordon, M. S., Schwartz, R. P., O\u2019Grady, K., Fitzgerald, T. T., & Wilson, M. (2007). A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence, 91, 220\u2013227. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.05.022.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1525\/fsr.2002.15.1.58","volume":"15","author":"PA Langan","year":"2002","unstructured":"Langan, P. A., & Levin, D. J. (2002). Recidivism of prisoners released in 1994. Federal Sentencing Reporter, 15, 58\u201365. https:\/\/doi.org\/10.1525\/fsr.2002.15.1.58.","journal-title":"Federal Sentencing Reporter"},{"key":"209_CR31","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/add.12894","volume":"110","author":"JD Lee","year":"2015","unstructured":"Lee, J. D., McDonald, R., Grossman, E., McNeely, J., Laska, E., Rotrosen, J., & Gourevitch, M. N. (2015). Opioid treatment at release from jail using extended-release naltrexone: A pilot proof-of-concept randomized effectiveness trial. Addiction (Abingdon, England), 110, 1008\u20131014. https:\/\/doi.org\/10.1111\/add.12894.","journal-title":"Addiction (Abingdon, England)"},{"key":"209_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jsat.2017.04.002","volume":"85","author":"T Lincoln","year":"2018","unstructured":"Lincoln, T., Johnson, B. D., McCarthy, P., & Alexander, E. (2018). Extended-release naltrexone for opioid use disorder started during or following incarceration. Journal of Substance Abuse Treatment, 85, 97\u2013100. https:\/\/doi.org\/10.1016\/j.jsat.2017.04.002.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"209_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","volume":"99","author":"S Magura","year":"2009","unstructured":"Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009). Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial. Drug and Alcohol Dependence, 99, 222\u2013230. https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.08.006.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/002204269302300106","volume":"23","author":"S Magura","year":"1993","unstructured":"Magura, S., Rosenblum, A., Lewis, C., & Joseph, H. (1993). The effectiveness of in-jail methadone maintenance. Journal of Drug Issues, 23, 75\u201399. https:\/\/doi.org\/10.1177\/002204269302300106.","journal-title":"Journal of Drug Issues"},{"key":"209_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jsat.2015.11.004","volume":"62","author":"JA Maradiaga","year":"2016","unstructured":"Maradiaga, J. A., Nahvi, S., Cunningham, C. O., Sanchez, J., & Fox, A. D. (2016). \u201cI kicked the hard way. I got incarcerated.\u201d Withdrawal from methadone during incarceration and subsequent aversion to medication assisted treatments. Journal of Substance Abuse Treatment, 62, 49\u201354.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"209_CR36","doi-asserted-by":"publisher","first-page":"CD002209","DOI":"10.1002\/14651858.CD002209.pub2","volume":"2010","author":"RP Mattick","year":"2009","unstructured":"Mattick, R. P., Breen, C., Kimber, J., Davoli, M., & Mattick, R. P. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Library, 2010, CD002209. https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2.","journal-title":"Cochrane Library"},{"key":"209_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/08897077.2011.609446","volume":"33","author":"M McKenzie","year":"2012","unstructured":"McKenzie, M., Zaller, N., Dickman, S. L., Green, T. C., Parihk, A., Friedmann, P. D., & Rich, J. D. (2012). A randomized trial of methadone initiation prior to release from incarceration. Substance Abuse, 33, 19\u201329. https:\/\/doi.org\/10.1080\/08897077.2011.609446.","journal-title":"Substance Abuse"},{"key":"209_CR38","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","volume":"105","author":"ELC Merrall","year":"2010","unstructured":"Merrall, E. L. C., Kariminia, A., Binswanger, I. A., Hobbs, M. S., Farrell, M., Marsden, J., \u2026 Bird, S. M. (2010). Meta-analysis of drug-related deaths soon after release from prison. Addiction (Abingdon, England), 105, 1545\u20131554. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.02990.x.","journal-title":"Addiction (Abingdon, England)"},{"key":"209_CR39","volume-title":"Correctional populations in the United States, 2019 \u2013 Statistical tables","author":"TD Minton","year":"2021","unstructured":"Minton, T. D., Beatty, L. G., & Zeng, Z. (2021). U. S. Department of Justice. In  Correctional populations in the United States, 2019 \u2013 Statistical tables https:\/\/bjs.ojp.gov\/sites\/g\/files\/xyckuh236\/files\/media\/document\/cpus19st.pdf."},{"key":"209_CR40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.puhe.2010.08.012","volume":"124","author":"LF M\u00f8ller","year":"2010","unstructured":"M\u00f8ller, L. F., Matic, S., van den Bergh, B. J., Moloney, K., Hayton, P., & Gatherer, A. (2010). Acute drug-related mortality of people recently released from prisons. Public Health (London), 124, 637\u2013639. https:\/\/doi.org\/10.1016\/j.puhe.2010.08.012.","journal-title":"Public Health (London)"},{"key":"209_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/ADM.0000000000000381","volume":"12","author":"KE Moore","year":"2018","unstructured":"Moore, K. E., Oberleitner, L., Smith, K. M. Z., Maurer, K., & McKee, S. A. (2018). Feasibility and effectiveness of continuing methadone maintenance treatment during incarceration compared with forced withdrawal. Journal of Addiction Medicine, 12, 156\u2013162. https:\/\/doi.org\/10.1097\/ADM.0000000000000381.","journal-title":"Journal of Addiction Medicine"},{"key":"209_CR42","volume-title":"Drug use and dependence, state and federal prisoners, 2004","author":"CJ Mumola","year":"2007","unstructured":"Mumola, C. J., Karberg, J. C., & United States. Bureau of Justice Statistics (2007). Drug use and dependence, state and federal prisoners, 2004. Washington, D.C.: U.S. Dept. of Justice, Office of Justice Programs, Bureau of Justice Statistics."},{"key":"209_CR43","volume-title":"Criminal justice drug facts","author":"National Institute on Drug Abuse","year":"2020","unstructured":"National Institute on Drug Abuse. (2020). Criminal justice drug facts. https:\/\/nida.nih.gov\/publications\/drugfacts\/criminal-justice"},{"issue":"1\u20132","key":"209_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","volume":"105","author":"A Nunn","year":"2009","unstructured":"Nunn, A., Zaller, N., Dickman, S., Trimbur, C., Nijhawan, A., & Rich, J. D. (2009). Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey. Drug and Alcohol Dependence, 105(1\u20132), 83\u201388.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR45","volume-title":"More imprisonment does not reduce state drug problems","author":"Pew","year":"2018","unstructured":"Pew. (2018). More imprisonment does not reduce state drug problems. https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/issue-briefs\/2018\/03\/more-imprisonment-does-not-reduce-state-drug-problems"},{"key":"209_CR46","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","volume":"386","author":"J Rich","year":"2015","unstructured":"Rich, J., McKenzie, M., Larney, S., Wong, J., Tran, L., Clarke, J., \u2026 Zaller, N. (2015). Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet, 386, 350\u2013359. https:\/\/doi.org\/10.1016\/S0140-6736(14)62338-2.","journal-title":"Lancet"},{"key":"209_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2020.108392","volume":"218","author":"R Schwartz","year":"2021","unstructured":"Schwartz, R., Kelly, S., Mitchell, S., O\u2019Grady, K., Duren, T., Sharma, A., \u2026 Jaffe, J. (2021). Randomized trial of methadone treatment of arrestees: 24-month post-release outcomes. Drug and Alcohol Dependence, 218, 1\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108392.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR48","doi-asserted-by":"publisher","first-page":"107680","DOI":"10.1016\/j.drugalcdep.2019.107680","volume":"206","author":"RP Schwartz","year":"2020","unstructured":"Schwartz, R. P., Kelly, S. M., Mitchell, S. G., O\u2019Grady, K. E., Sharma, A., & Jaffe, J. H. (2020). Methadone treatment of arrestees: A randomized clinical trial. Drug and Alcohol Dependence, 206, 107680\u2013107680. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107680.","journal-title":"Drug and Alcohol Dependence"},{"key":"209_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40352-021-00143-9","volume":"9","author":"CK Scott","year":"2021","unstructured":"Scott, C. K., Dennis, M. L., Grella, C. E., Mischel, A. F., & Carnevale, J. (2021). The impact of the opioid crisis on U.S. state prison systems. Health & Justice, 9, 17\u201317. https:\/\/doi.org\/10.1186\/s40352-021-00143-9.","journal-title":"Health & Justice"},{"key":"209_CR50","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., \u2026 Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ, 357, j1550\u2013j1564. https:\/\/doi.org\/10.1136\/bmj.j1550.","journal-title":"BMJ"},{"key":"209_CR51","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1086\/317607","volume":"182","author":"LE Thorpe","year":"2000","unstructured":"Thorpe, L. E., Ouellet, L. J., Levy, J. R., Williams, I. T., & Monterroso, E. R. (2000). Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997\u20131999. The Journal of Infectious Diseases, 182, 1588\u20131594. https:\/\/doi.org\/10.1086\/317607.","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"209_CR52","first-page":"14","volume":"68","author":"V Tomasino","year":"2001","unstructured":"Tomasino, V., Swanson, A. J., Nolan, J., & Shuman, H. I. (2001). The key extended entry program (KEEP): A methadone treatment program for opiate-dependent inmates. The Mount Sinai Journal of Medicine, 68(1), 14\u201320.","journal-title":"The Mount Sinai Journal of Medicine"},{"key":"209_CR53","volume-title":"The Americans with disabilities act and the opioid crisis: Combatting discrimination against people in treatment or recovery","author":"U.S. Department of Justice","year":"2022","unstructured":"U.S. Department of Justice (2022). The Americans with disabilities act and the opioid crisis: Combatting discrimination against people in treatment or recovery. Civil Rights Division https:\/\/www.ada.gov\/opioid_guidance.pdf."},{"issue":"37","key":"209_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-019-0166-0","volume":"14","author":"M Velasquez","year":"2019","unstructured":"Velasquez, M., Flannery, M., Badolato, R., Vittitow, A., McDonald, R. D., Tofighi, B., \u2026 Lee, J. D. (2019). Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Addiction Science & Clinical Practice, 14(37), 1\u201312. https:\/\/doi.org\/10.1186\/s13722-019-0166-0.","journal-title":"Addiction Science & Clinical Practice"},{"issue":"8","key":"209_CR55","first-page":"133","volume":"61","author":"C Wejnert","year":"2012","unstructured":"Wejnert, C., Oster, A. M., DiNenno, E. A., Smith, A., Krishna, N., & Lansky, A. (2012). HIV infection and HIV-associated behaviors among injecting drug Users-20 cities, United States, 2009. Morbidity and Mortality Weekly Report, 61(8), 133\u2013138.","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"108355","key":"209_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2021.108355","volume":"127","author":"GE Woody","year":"2021","unstructured":"Woody, G. E., Poole, S., Yu, E., Carroll, J., & Lynch, K. G. (2021). Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison. Journal of Substance Abuse Treatment, 127(108355), 1\u201310. https:\/\/doi.org\/10.1016\/j.jsat.2021.108355.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"209_CR57","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","volume":"45","author":"N Zaller","year":"2013","unstructured":"Zaller, N., McKenzie, M., Friedmann, P. D., Green, T. C., McGowan, S., & Rich, J. D. (2013). Initiation of buprenorphine during incarceration and retention in treatment upon release. Journal of Substance Abuse Treatment, 45, 222\u2013226. https:\/\/doi.org\/10.1016\/j.jsat.2013.02.005.","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Health &amp; Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-023-00209-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40352-023-00209-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-023-00209-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T04:56:21Z","timestamp":1675486581000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthandjusticejournal.biomedcentral.com\/articles\/10.1186\/s40352-023-00209-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["209"],"URL":"https:\/\/doi.org\/10.1186\/s40352-023-00209-w","relation":{},"ISSN":["2194-7899"],"issn-type":[{"value":"2194-7899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}